{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:08:00Z","timestamp":1778562480172,"version":"3.51.4"},"reference-count":52,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Metabolic dysfunction-associated steatohepatitis (MASH) is a complex, multifactorial disease heavily influenced by the gut\u2013liver axis. While enterotoxigenic Bacteroides fragilis (ETBF) and its principal virulence factor, B. fragilis toxin (BFT)\u2014a zinc-dependent metalloprotease\u2014are well-known for disrupting intestinal barriers, their potential systemic impact on distant organs remains an emerging area of interest. Although various gut-derived factors contribute to hepatic inflammation, the precise molecular triggers that exacerbate the transition from simple steatosis to progressive fibrosis remain incompletely understood. This review proposes the \u201cDirect Structural Disruption\u201d hypothesis, examining the biological activity of BFT and its proposed role in MASH pathogenesis. We postulate that under permissive conditions, systemic BFT may target hepatic structural proteins (e.g., cadherins). This hypothesized architectural impairment amplifies canonical fibrogenic signaling and hepatic stellate cell (HSC) activation. In addition, we discuss current challenges in the detection and characterization of systemic BFT, particularly the technical limitations in clinical diagnostics stemming from its profound structural homology with host metalloproteinases. Future research integrating advanced diagnostic methodologies and liver-specific in vivo models is essential to elucidate these pathophysiological mechanisms and evaluate the ETBF-BFT axis as a complementary target in progressive MASH.<\/jats:p>","DOI":"10.3390\/toxins18050200","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:28:23Z","timestamp":1777040903000},"page":"200","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The \u201cDirect Structural Disruption\u201d Hypothesis: Bacteroides fragilis Toxin as a Potentiating Cofactor in MASH Pathogenesis"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5357-4476","authenticated-orcid":false,"given":"Ju-Eun","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Biomedical Laboratory Science, College of Software Digital Healthcare Convergence, Yonsei University MIRAE Campus, Wonju 26493, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1904-077X","authenticated-orcid":false,"given":"Soonjae","family":"Hwang","sequence":"additional","affiliation":[{"name":"Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Incheon 21983, Republic of Korea"},{"name":"G-FRIS (Green-Futures Research Institute of Science), G-LAMP, Yonsei University, Seoul 03722, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1073\/pnas.95.25.14979","article-title":"Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin","volume":"95","author":"Wu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/CMR.00053-08","article-title":"Enterotoxigenic Bacteroides fragilis: A rogue among symbiotes","volume":"22","author":"Sears","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1158\/2159-8290.CD-20-0537","article-title":"A Procarcinogenic Colon Microbe Promotes Breast Tumorigenesis and Metastatic Progression and Concomitantly Activates Notch and beta-Catenin Axes","volume":"11","author":"Parida","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Caparros","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"12502","DOI":"10.1038\/ncomms12502","article-title":"PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis","volume":"7","author":"Martin","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/CMR.00008-07","article-title":"Bacteroides: The good, the bad, and the nitty-gritty","volume":"20","author":"Wexler","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1128\/IAI.01348-10","article-title":"Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut","volume":"79","author":"Zitomersky","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1128\/IAI.00814-08","article-title":"Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL\/6 mice","volume":"77","author":"Rhee","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1073\/pnas.1012173108","article-title":"Structure, function and latency regulation of a bacterial enterotoxin potentially derived from a mammalian adamalysin\/ADAM xenolog","volume":"108","author":"Goulas","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1038\/s41467-024-53658-8","article-title":"Molecular mimicry as a mechanism of viral immune evasion and autoimmunity","volume":"15","author":"Maguire","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Van Avondt, K., van Sorge, N.M., and Meyaard, L. (2015). Bacterial immune evasion through manipulation of host inhibitory immune signaling. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004644"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/s42003-025-09280-5","article-title":"Nicotine exacerbates MASH via inducing intestinal dysbiosis and barrier dysfunction","volume":"8","author":"Yi","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3748\/wjg.v18.i9.923","article-title":"High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids","volume":"18","author":"Stenman","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Shvirst, A.N., Mamedov, T.V., Butanaev, A.A., Pogorelov, A.G., and Chuev, G.N. (2026). Biophysical Modeling of Lipopolysaccharides in Gram-Negative Bacteria: From Atomic to Colloidal Models. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27052488"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/iai.60.4.1343-1350.1992","article-title":"Purification and characterization of an enterotoxin from Bacteroides fragilis","volume":"60","author":"Lyerly","year":"1992","journal-title":"Infect. Immun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12551-020-00699-0","article-title":"Biophysical nanocharacterization of liver sinusoidal endothelial cells through atomic force microscopy","volume":"12","author":"Zapotoczny","year":"2020","journal-title":"Biophys. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nm.4077","article-title":"Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice","volume":"22","author":"Choi","year":"2016","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jmb.2011.01.031","article-title":"Structure and binding mechanism of vascular endothelial cadherin: A divergent classical cadherin","volume":"408","author":"Brasch","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1113\/JP275328","article-title":"Cadherins: Cellular adhesive molecules serving as signalling mediators","volume":"596","author":"Yulis","year":"2018","journal-title":"J. Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gibert-Ramos, A., Sanfeliu-Redondo, D., Aristu-Zabalza, P., Martinez-Alcocer, A., Gracia-Sancho, J., Guixe-Muntet, S., and Fernandez-Iglesias, A. (2021). The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer. Cancers, 13.","DOI":"10.3390\/cancers13225719"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2015.06.015","article-title":"Structural and functional hepatocyte polarity and liver disease","volume":"63","author":"Gissen","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Du, W., and Wang, L. (2022). The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.936196"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1073\/pnas.1322731111","article-title":"Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis","volume":"111","author":"Nakagawa","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2010.04.031","article-title":"Hepatocellular ballooning in NASH","volume":"53","author":"Caldwell","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12964-023-01183-4","article-title":"Anoikis resistance\u2014Protagonists of breast cancer cells survive and metastasize after ECM detachment","volume":"21","author":"Dai","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Saga, K., Iwashita, Y., Hidano, S., Aso, Y., Isaka, K., Kido, Y., Tada, K., Takayama, H., Masuda, T., and Hirashita, T. (2018). Secondary Unconjugated Bile Acids Induce Hepatic Stellate Cell Activation. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19103043"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s42003-024-07192-4","article-title":"The acidic microenvironment in the perisinusoidal space critically determines bile salt-induced activation of hepatic stellate cells","volume":"7","author":"Li","year":"2024","journal-title":"Commun. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00418-006-0233-y","article-title":"Switch of cadherin expression from E- to N-type during the activation of rat hepatic stellate cells","volume":"127","author":"Lim","year":"2007","journal-title":"Histochem. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.1073\/pnas.1103345108","article-title":"E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components","volume":"108","author":"Kim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3350\/cmh.2022.0058","article-title":"Wnt signaling in liver regeneration, disease, and cancer","volume":"29","author":"Zou","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.7150\/thno.106597","article-title":"Metabolism of hepatic stellate cells in chronic liver diseases: Emerging molecular and therapeutic interventions","volume":"15","author":"Yan","year":"2025","journal-title":"Theranostics"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"30142","DOI":"10.1074\/jbc.M115.676239","article-title":"Hepatic Xbp1 Gene Deletion Promotes Endoplasmic Reticulum Stress-induced Liver Injury and Apoptosis","volume":"290","author":"Olivares","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12967-022-03759-z","article-title":"Targeting HSP47 and HSP70: Promising therapeutic approaches in liver fibrosis management","volume":"20","author":"Zakaria","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.chembiol.2025.12.009","article-title":"Mechanistic diversity of Bacteroides fragilis toxins and neutralization with single domain antibody","volume":"33","author":"Guo","year":"2026","journal-title":"Cell Chem. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e13674","DOI":"10.1111\/aji.13674","article-title":"Soluble E-cadherin: A marker of genital epithelial disruption","volume":"89","author":"Liu","year":"2023","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/jnci\/djab212","article-title":"Cancer Microbiology","volume":"114","author":"DiMaio","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Hu, X., Xiong, Y., Villodre, E.S., Zhang, H., Longa, I.R., Song, J., Fowlkes, N., Krishnamurthy, S., Rylander, M., and Bartholomeusz, C. (2026). Soluble E-cadherin-CXCL1-CXCR2 Axis as a Therapeutic Vulnerability in Inflammatory Breast Cancer Brain Metastasis. Neuro-Oncology, noag012.","DOI":"10.1093\/neuonc\/noag012"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41575-024-00915-2","article-title":"Spatial genomics: Mapping human steatotic liver disease","volume":"21","author":"Matchett","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/5\/200\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:11:30Z","timestamp":1778559090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/18\/5\/200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["toxins18050200"],"URL":"https:\/\/doi.org\/10.3390\/toxins18050200","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}